期刊文献+

胃癌耐药细胞多药耐药基因表达上调中AP-1作用的研究 被引量:5

The Role of AP-1 in the Upregulation of the Multidrug Resistance Gene MDR1 in a Drug-Resistant Gastric Carcinoma Cell Line
下载PDF
导出
摘要 目的:探讨人胃腺癌阿霉素耐药细胞系SGC7901/ADR中多药耐药(multi drug resistance,MDR)产生机制,为胃癌多药耐药机制的研究提供新靶点。方法:采用MTT法测定3种常用化疗药物顺铂、表柔比星、5-氟尿嘧啶在人胃癌细胞系SGC7901及其阿霉素耐药细胞系SGC7901/ADR中的作用;应用反转录聚合酶链反应(RT-PCR)技术检测SGC7901和SGC7901/ADR中mdr1、c-Jun的mRNA表达情况;转录因子AP-1分别转染入SGC7901和SGC7901/ADR中,应用双荧光素报告基因检测系统(Dual-Luciferase reporter assay system)检测其活性;Western Blot法检测P-gp、c-Jun在蛋白水平的表达。结果:SGC7901与SGC7901/ADR在化疗药物顺铂、表柔比星、5-氟尿嘧啶的不同浓度下作用72小时后,发现SGC7901/ADR中细胞的生存率无明显改变,而SGC7901的生存率却有显著的下降趋势;在mRNA水平对mdr1基因进行检测,SGC7901/ADR中的多药耐药基因的表达显著高于SGC7901,而P-gp在蛋白水平的检测中显示SGC7901/ADR相对与SGC7901,表达活性有明显升高;转录因子AP-1的表达分别在SGC7901及SGC7901/ADR中检测到,但SGC7901/ADR中AP-1的活性明显高于SGC7901;AP-1的主要组成成份c-Jun在SGC7901和SGC7901/ADR做mRNA及蛋白水平的检测,结果显示在SGC7901中未发现c-Jun的明显表达,而SGC7901/ADR中c-Jun的表达活性均显著升高。结论:在人胃腺癌阿霉素耐药细胞系SGC7901/ADR中有MDR的产生,同时伴多药耐药基因上调;转录因子AP-1的活性表达与胃癌细胞的多药耐药性密切相关,AP-1的表达高低可能是其形成机制之一。 Objective: To investigate the role of the muhi-drug resistanee gene MDRI in the Doxorubicin-resistant SGC7901/ADR gastric adenocarcinoma cell line. Methods: We used the MTT assay to determine the cell survival rate of SGC7901 human gastric careinoma cells and Doxorubicin-resistant SGC7901/ADR cells 'after treatment with three kinds of commonly used chemotherapeutic drugs. Reverse transcription-polymerase chain reaction (RT-PCR) was employed to detect the mRNA level of mdrl and c-Jun in SGC7901 and SGC7901/ADR cells. Transcription factor AP-1 was transfected into SGC7901 and SGC7901/ADR cells, and tire transcription activity was assayed by a dual-luciferase reporter assay. The protein expression of P-gp and c-Jun was detected by Western blot, Results: The survival rate of SGC7901/ADR cells was significantly higher than that of SGC7901 cells. The mRNA level of mdrl and c-Jun was significantly higher in SGC7901/ADR cells than in SGC7901 cells. The transcription activity of transcription factor AP-1 was different between the two cell lines. The levels of P-gp anti c-Jun were higher in SGC7901/ADR cells. Conclusion: In the SGC7901/ADR cell line.multiple-drug resistance is increased and an upregulation of the MDR1 gene is observed. In gastric cancer, the activity of transcription factor AP-1 is related to the MDR of cancer cells. The expression of AP-1 may be involved in the mechanism of Doxorubicin resistance in gastric carcinoma cells.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2008年第10期582-586,共5页 Chinese Journal of Clinical Oncology
基金 国家自然科学基金(编号:30471994) 上海市科委浦江人才计划项目(编号:045407047) 上海市教育委员会“曙光计划”项目资助(编号:99SG24)
关键词 胃癌 多药耐药 AP-1 Gastric carcinoma Multi-drug resistance Activator protein-1
  • 相关文献

参考文献12

  • 1Khan FA, Shukla AN, et al, Pathogenesis and treatment of gastric carcinoma: "an up-date with brief review"[J]. J Cancer Res Ther, 2006, 2(4): 196-199.
  • 2Kawabata K, Murakami A, Ohigashi H. Nobiletin, a citrus flavonoid, down-regulates matrix metalloproteinase-7 (matrilysin) expression in HT-29 human colorectal cancer cells [J]. Biosci Biotechnol Biochem, 2005, 69(2): 307-314.
  • 3Hong S, Park KK, Magae J, et al. Ascochlorin inhibits matrix metalloproteinase-9 expression by suppressing activator protein- 1--mediated gene expression through the ERKI/2 signaling pathway: inhibitory effects of ascochlorin on the invasion of renal carcinoma cells[J].J Biol Ghem, 2005, 280(26): 25202-25209.
  • 4McCarty MF. Polyphenol-mediated inhibition of AP-1 transactivating activity may slow cancer growth by impeding angiogenesis and tumor invasiveness[J]. Med Hypotheses, 1998, 50: 511-514.
  • 5Rao ChV, Li X, Manna SK, et al. Human chorionic gonadotropin decreases proliferation and invasion of breast cancer MCF-7 cells by inhibiting NF-kappaB and AP-1 activation [J]. J Biol Chem, 2004, 279(24): 25503-25510.
  • 6Bonovich M, Olive M, Reed E, et al. Adenoviral delivery of AFOS, an AP-1 dominant negative, selectively inhibits drug resistance in two human cancer ceU lines[J]. Cancer Gene Ther, 2002,9(1): 62-70.
  • 7李正友,张长松,郭献灵,程越,卜欣欣,李蓉,贾凤岐,李云龙,吴孟超,卫立辛.DNA去甲基化对肝细胞人端粒酶逆转录酶上调的研究[J].中国肿瘤临床,2007,34(2):61-64. 被引量:8
  • 8郭献灵,王晋,马楠楠,贾凤歧,卜欣欣,李正友,范瑞芳,李蓉,吴孟超,卫立辛.胃癌多药耐药细胞端粒酶活性变化及其机制探讨[J].中国肿瘤临床,2007,34(22):1270-1274. 被引量:2
  • 9陈晓耕,王清水,陈新,施作霖.多药耐药基因产物表达和细胞凋亡对胃癌影响的研究[J].中华肿瘤杂志,2000,22(6):487-489. 被引量:23
  • 10Shinoda C, Maruyama M, Fujishita T, et al. Doxorubicin induces expression of multidrug resistance--associated protein 1 in human small cell lung cancer cell lines by the c--jun N--terminal kinase pathway[]]. Int J Gancer, 2005, 117(1): 21-31.

二级参考文献11

共引文献30

同被引文献55

  • 1杨学宁,吴一龙.实体瘤治疗疗效评价标准——RECIST[J].循证医学,2004,4(2):85-90. 被引量:1520
  • 2沈松杰,郭俊超,廖泉,赵玉沛.MAPK信号转导通路在肿瘤化疗耐药中的作用[J].国外医学(肿瘤学分册),2005,32(8):579-582. 被引量:9
  • 3周长春,刘芝华,齐军.AP-1和肿瘤的关系研究进展[J].世界华人消化杂志,2006,14(1):1-5. 被引量:15
  • 4王强,董频,王文栋,徐成志,王国良.喉癌中p14ARF基因缺失与mdm2、c-jun蛋白的表达[J].中国耳鼻咽喉头颈外科,2006,13(2):74-76. 被引量:1
  • 5宋玉华,郭宁,宋三泰,江泽飞.Fra-1原癌基因研究进展[J].军事医学科学院院刊,2006,30(5):490-493. 被引量:5
  • 6Song Y, Qian L, Song S, et al. Fra-1 and Stat3 synergistically regulate activation of human MMP-9 geneS. Mol Immunol, 2008, 45 (1): 137-143.
  • 7Rarnos-Nino ME, Blumen SR, Pass H, et al. Fra-1 governs cell figration via modulation of CD44 expression in human mesothefioaas[J]. Mol Cancer, 2007, 6: 81.
  • 8Adiseshaiah P, Lindner DJ, Kalvakolanu DV, et al. FRA-1 proto-oncogene induces lung epithelial cell invasion and anchorage-independent growth in vitro, but is insufficient to promote tumor growth in vivo[J]. Cancer Res, 2007, 67(13): 6204-6211.
  • 9Rorke EA, Adhikary G, Jans R, et al. AP1 factor inactivation in the suprabasal epidermis causes increased epidermal hyperproliferation and hyperkeratosis but reduced carcinogen-dependent tumor formation[J]. Oncogene, 2010, 29(44): 5873-5882.
  • 10Chiappetta G, Ferraro A, Botti G, et al. FRA-1 protein overexpression is a feature of hyperplastic and neoplastic breast disorders[J]. BMC Cancer, 2007, 7: 17.

引证文献5

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部